Literature DB >> 21671394

Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome.

Mark C Hannibal1, Kati J Buckingham, Sarah B Ng, Jeffrey E Ming, Anita E Beck, Margaret J McMillin, Heidi I Gildersleeve, Abigail W Bigham, Holly K Tabor, Heather C Mefford, Joseph Cook, Koh-ichiro Yoshiura, Tadashi Matsumoto, Naomichi Matsumoto, Noriko Miyake, Hidefumi Tonoki, Kenji Naritomi, Tadashi Kaname, Toshiro Nagai, Hirofumi Ohashi, Kenji Kurosawa, Jia-Woei Hou, Tohru Ohta, Deshung Liang, Akira Sudo, Colleen A Morris, Siddharth Banka, Graeme C Black, Jill Clayton-Smith, Deborah A Nickerson, Elaine H Zackai, Tamim H Shaikh, Dian Donnai, Norio Niikawa, Jay Shendure, Michael J Bamshad.   

Abstract

Kabuki syndrome is a rare, multiple malformation disorder characterized by a distinctive facial appearance, cardiac anomalies, skeletal abnormalities, and mild to moderate intellectual disability. Simplex cases make up the vast majority of the reported cases with Kabuki syndrome, but parent-to-child transmission in more than a half-dozen instances indicates that it is an autosomal dominant disorder. We recently reported that Kabuki syndrome is caused by mutations in MLL2, a gene that encodes a Trithorax-group histone methyltransferase, a protein important in the epigenetic control of active chromatin states. Here, we report on the screening of 110 families with Kabuki syndrome. MLL2 mutations were found in 81/110 (74%) of families. In simplex cases for which DNA was available from both parents, 25 mutations were confirmed to be de novo, while a transmitted MLL2 mutation was found in two of three familial cases. The majority of variants found to cause Kabuki syndrome were novel nonsense or frameshift mutations that are predicted to result in haploinsufficiency. The clinical characteristics of MLL2 mutation-positive cases did not differ significantly from MLL2 mutation-negative cases with the exception that renal anomalies were more common in MLL2 mutation-positive cases. These results are important for understanding the phenotypic consequences of MLL2 mutations for individuals and their families as well as for providing a basis for the identification of additional genes for Kabuki syndrome.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21671394      PMCID: PMC3121928          DOI: 10.1002/ajmg.a.34074

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  12 in total

1.  Mutations in a new member of the chromodomain gene family cause CHARGE syndrome.

Authors:  Lisenka E L M Vissers; Conny M A van Ravenswaaij; Ronald Admiraal; Jane A Hurst; Bert B A de Vries; Irene M Janssen; Walter A van der Vliet; Erik H L P G Huys; Pieter J de Jong; Ben C J Hamel; Eric F P M Schoenmakers; Han G Brunner; Joris A Veltman; Ad Geurts van Kessel
Journal:  Nat Genet       Date:  2004-08-08       Impact factor: 38.330

Review 2.  Chromatin modifications and their function.

Authors:  Tony Kouzarides
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

Review 3.  Clinical and molecular overview of inherited disorders resulting from epigenomic dysregulation.

Authors:  Albertina De Sario
Journal:  Eur J Med Genet       Date:  2009-07-24       Impact factor: 2.708

Review 4.  Kabuki make-up (Niikawa-Kuroki) syndrome: a study of 62 patients.

Authors:  N Niikawa; Y Kuroki; T Kajii; N Matsuura; S Ishikiriyama; H Tonoki; N Ishikawa; Y Yamada; M Fujita; H Umemoto
Journal:  Am J Med Genet       Date:  1988-11

5.  MLL2: A new mammalian member of the trx/MLL family of genes.

Authors:  K T FitzGerald; M O Diaz
Journal:  Genomics       Date:  1999-07-15       Impact factor: 5.736

Review 6.  Kabuki syndrome: a review.

Authors:  M P Adam; L Hudgins
Journal:  Clin Genet       Date:  2005-03       Impact factor: 4.438

7.  Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome.

Authors:  Sarah B Ng; Abigail W Bigham; Kati J Buckingham; Mark C Hannibal; Margaret J McMillin; Heidi I Gildersleeve; Anita E Beck; Holly K Tabor; Gregory M Cooper; Heather C Mefford; Choli Lee; Emily H Turner; Joshua D Smith; Mark J Rieder; Koh-Ichiro Yoshiura; Naomichi Matsumoto; Tohru Ohta; Norio Niikawa; Deborah A Nickerson; Michael J Bamshad; Jay Shendure
Journal:  Nat Genet       Date:  2010-08-15       Impact factor: 38.330

8.  Growth, behavior, and clinical findings in 27 patients with Kabuki (Niikawa-Kuroki) syndrome.

Authors:  S M White; E M Thompson; A Kidd; R Savarirayan; A Turner; D Amor; M B Delatycki; M Fahey; A Baxendale; S White; E Haan; K Gibson; J L Halliday; A Bankier
Journal:  Am J Med Genet A       Date:  2004-06-01       Impact factor: 2.802

9.  A new malformation syndrome of long palpebral fissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation.

Authors:  Y Kuroki; Y Suzuki; H Chyo; A Hata; I Matsui
Journal:  J Pediatr       Date:  1981-10       Impact factor: 4.406

10.  Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency.

Authors:  N Niikawa; N Matsuura; Y Fukushima; T Ohsawa; T Kajii
Journal:  J Pediatr       Date:  1981-10       Impact factor: 4.406

View more
  64 in total

1.  How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum.

Authors:  Siddharth Banka; Ratna Veeramachaneni; William Reardon; Emma Howard; Sancha Bunstone; Nicola Ragge; Michael J Parker; Yanick J Crow; Bronwyn Kerr; Helen Kingston; Kay Metcalfe; Kate Chandler; Alex Magee; Fiona Stewart; Vivienne P M McConnell; Deirdre E Donnelly; Siren Berland; Gunnar Houge; Jenny E Morton; Christine Oley; Nicole Revencu; Soo-Mi Park; Sally J Davies; Andrew E Fry; Sally Ann Lynch; Harinder Gill; Susann Schweiger; Wayne W K Lam; John Tolmie; Shehla N Mohammed; Emma Hobson; Audrey Smith; Moira Blyth; Christopher Bennett; Pradeep C Vasudevan; Sixto García-Miñaúr; Alex Henderson; Judith Goodship; Michael J Wright; Richard Fisher; Richard Gibbons; Susan M Price; Deepthi C de Silva; I Karen Temple; Amanda L Collins; Katherine Lachlan; Frances Elmslie; Meriel McEntagart; Bruce Castle; Jill Clayton-Smith; Graeme C Black; Dian Donnai
Journal:  Eur J Hum Genet       Date:  2011-11-30       Impact factor: 4.246

2.  De novo loss-of-function mutations in SETD5, encoding a methyltransferase in a 3p25 microdeletion syndrome critical region, cause intellectual disability.

Authors:  Detelina Grozeva; Keren Carss; Olivera Spasic-Boskovic; Michael J Parker; Hayley Archer; Helen V Firth; Soo-Mi Park; Natalie Canham; Susan E Holder; Meredith Wilson; Anna Hackett; Michael Field; James A B Floyd; Matthew Hurles; F Lucy Raymond
Journal:  Am J Hum Genet       Date:  2014-03-27       Impact factor: 11.025

3.  A non-active-site SET domain surface crucial for the interaction of MLL1 and the RbBP5/Ash2L heterodimer within MLL family core complexes.

Authors:  Stephen A Shinsky; Michael Hu; Valarie E Vought; Sarah B Ng; Michael J Bamshad; Jay Shendure; Michael S Cosgrove
Journal:  J Mol Biol       Date:  2014-03-27       Impact factor: 5.469

Review 4.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

Review 5.  Examining the impact of gene variants on histone lysine methylation.

Authors:  Capucine Van Rechem; Johnathan R Whetstine
Journal:  Biochim Biophys Acta       Date:  2014-05-23

6.  Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization.

Authors:  Hiroyuki Kato; Kaori Asamitsu; Wendi Sun; Shojiro Kitajima; Naoko Yoshizawa-Sugata; Takashi Okamoto; Hisao Masai; Lorenz Poellinger
Journal:  Oncogene       Date:  2020-02-18       Impact factor: 9.867

Review 7.  Genetics and signaling mechanisms of orofacial clefts.

Authors:  Kurt Reynolds; Shuwen Zhang; Bo Sun; Michael A Garland; Yu Ji; Chengji J Zhou
Journal:  Birth Defects Res       Date:  2020-07-15       Impact factor: 2.344

8.  Mirror-image asymmetry in monozygotic twins with kabuki syndrome.

Authors:  A Riess; A Dufke; O Riess; S Beck-Woedl; B Fode; H Skladny; R Klaes; A Tzschach
Journal:  Mol Syndromol       Date:  2012-07-25

9.  A comparative analysis of KMT2D missense variants in Kabuki syndrome, cancers and the general population.

Authors:  Víctor Faundes; Geraldine Malone; William G Newman; Siddharth Banka
Journal:  J Hum Genet       Date:  2018-11-20       Impact factor: 3.172

10.  Trans-tail regulation of MLL4-catalyzed H3K4 methylation by H4R3 symmetric dimethylation is mediated by a tandem PHD of MLL4.

Authors:  Shilpa S Dhar; Sung-Hun Lee; Pu-Yeh Kan; Philipp Voigt; Li Ma; Xiaobing Shi; Danny Reinberg; Min Gyu Lee
Journal:  Genes Dev       Date:  2012-12-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.